Cargando…
Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study
Antihypertensive drug treatment is cost-effective for adults at high risk of developing cardiovascular disease (CVD). However, the cost-effectiveness in people with stage 1 hypertension (140–159 mm Hg systolic blood pressure) at lower CVD risk remains unclear. The objective was to establish the 10-y...
Autores principales: | Constanti, Margaret, Floyd, Christopher N., Glover, Mark, Boffa, Rebecca, Wierzbicki, Anthony S., McManus, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803450/ https://www.ncbi.nlm.nih.gov/pubmed/33342242 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.14913 |
Ejemplares similares
-
Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model
por: Constanti, Margaret, et al.
Publicado: (2020) -
Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis
por: Sheppard, James P, et al.
Publicado: (2014) -
Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial
por: Jowett, Sue, et al.
Publicado: (2022) -
Cost-effectiveness of a hypertension management programme in an elderly population: a Markov model
por: Perman, Gastón, et al.
Publicado: (2011) -
What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease?
por: Schwartz, Claire L., et al.
Publicado: (2015)